Vol. 11 No.7
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
2
ODs predict 2026: What's to come in technology, dry eye, and glaucoma
3
Pilocarpine 0.4%: Significant decrease in pupillary diameter in presbyopic patients
4
The unmet needs of glaucoma care with Dr Ben Casella
5
